Market Report on India Pharmaceutical & Healthcare Industry

Market reports on India presents the latest report on “Market Report on India Pharmaceutical & Healthcare Industry” http://www.marketreportsonindia.com/life-sciences-market-research-reports-3775/india-pharmaceutical-healthcare-industry.html The report also highlights leading players in the sector including Dr Reddy’s Laboratories Ltd, Cipla Ltd and Lupin Ltd.

17th Feb 2016, – Navi Mumbai, India: Market reports on India presents the latest report on “Market Report on India Pharmaceutical & Healthcare Industry”. Indian pharmaceutical companies have maintained the highest standards in purity, stability and international safety, health and environmental protection.

This report profiles India’s pharmaceuticals and healthcare industry, discussing market trends through 2015 and outlook for 2016 and beyond. The report also highlights leading players in the sector including Dr Reddy’s Laboratories Ltd, Cipla Ltd and Lupin Ltd.

Over the last decade, the Indian pharmaceutical and healthcare sector has taken great strides. India’s pharmaceutical sector has achieved new heights as the world’s most cost effective generic drugs manufacturer. Many Indian pharmaceutical companies have maintained the highest standards in purity, stability and international safety, health and environmental protection during the production process as well as the supply of bulk drugs. Competing fiercely with other emerging markets such as Brazil and China, India has carved a niche for itself in becoming one of the leading generic pharmaceutical manufacturers in the world.

The domestic pharmaceutical market continued on its growth trend in 2015, growing by 12% y/y. However, pharmaceuticals export growth slowed down further in the year due to the Indian rupee depreciation. Exports grew by only 4% in 2015, after experiencing double-digit growth of 11% in 2014. Going forward, a revival is expected in the sector backed by government support and various macro growth drivers, including rise in per...